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Abstract
Background: Managing multiple chronic and acute conditions in patients with multimorbidity
requires setting medical priorities. How family practitioners (FPs) rank medical priorities between
highly, moderately, or rarely prevalent chronic conditions (CCs) has never been described. The
authors hypothesised that there was no relationship between the prevalence of CCs and their
medical priority ranking in individual patients with multimorbidity.
Aim: To describe FPs’ medical priority ranking of conditions relative to their prevalence in patients
with multimorbidity.
Design & setting: This cross-sectional study of 100 FPs in Switzerland included patients with 3
CCs on a predefined list of 75 items from the International Classification of Primary Care 2 (ICPC-
2); other conditions could be added. FPs ranked all conditions by their medical priority.
Method: Priority ranking and distribution were calculated for each condition separately and for the
top three priorities together.
Results: The sample contained 888 patients aged 28–98 years (mean 73), of which 48.2% were
male. Included patients had 3–19 conditions (median 7; interquantile range [IQR] 6–9). FPs used 74/
75 CCs from the predefined list, of which 27 were highly prevalent (>5%). In total, 336 different
conditions were recorded. Highly prevalent CCs were only the top medical priority in 66%, and the
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first three priorities in 33%, of cases. No correlation was found between prevalence and the
ranking of medical priorities.
Conclusion: FPs faced a great diversity of different conditions in their patients with multimorbidity,
with nearly every condition being found at nearly every rank of medical priority, depending on the
patient. Medical priority ranking was independent of the prevalence of CCs.
How this fits in
The management of multimorbidity in primary care is complex, and FPs need to set medical
priorities. FPs’ rankings of medical priorities in the management of multimorbidity had never been
described previously.
No relationship was found between the medical priority ranking of different chronic or acute con-
ditions and their prevalence.
A better understanding of how FPs set their medical priorities could lead to better agreement
with patients’ priorities, which can be different, and to the creation of guidelines adapted to their
daily practice.
Introduction
Multimorbidity, defined as the co-occurrence of more than two or three chronic conditions (CCs) in
one person, is increasingly prevalent as global populations age.1–3 Multimorbidity is often present in
well-described patterns of highly prevalent CCs.4–9 The most frequent patterns associate cardiovas-
cular diseases and their risk factors, metabolic syndromes (such as diabetes and obesity), pulmonary
diseases, psychological disorders (such as depression and anxiety), and osteoarthritic
pain.10 However, the prevalence of multimorbidity varies greatly depending on definitions, the CCs
included, study design, populations, measures, and outcomes.1,11–16
Co-managing a patient’s multiple chronic and non-chronic conditions with different levels of
severity is often extremely challenging for FPs. They must therefore try to set medical priorities, as
the co-management of every condition present during the same consultation is often
impossible.17 FPs are trained to focus first on the clinical problems which pose the highest risk of
mortality or morbidity to the patient (such as heart diseases and diabetes), and this may be their way
of setting priorities.18
The innumerable combinations of different chronic and acute conditions found in primary
care make the management of patients with multimorbidity non-standard and often
complex.19 Most clinical practice guidelines provide recommendations for dealing with some of the
most prevalent CCs,20 but FPs face an extreme diversity of combinations of CCs; some of these
appear individually quite infrequently, but they have a high medical priority and therefore require an
in-depth assessment of how to treat them in the context of other CCs. Due to their relative uncom-
monness, such rare CCs are usually not integrated into studies on multimorbidity but are a daily
problem for FPs. Newer guidelines integrate the most frequent CCs, but this still does not solve
every problem for FPs, who cannot simply apply clinical recommendations generically to a specific
individual’s situation.20–23 It was therefore hypothesised that the highly prevalent and well-described
CCs were not always FPs’ top medical priorities in primary care.
The present study, therefore, aimed to describe FPs’ medical priority ranking of CCs in relation to
their prevalence for each individual multimorbid patient in a primary care study sample.
Method
The present study is a secondary analysis of the cross-sectional Multi-Morbidity in Family Medicine
(MMFM) study of patients with multimorbidity in primary care in Switzerland.24 The detailed study
protocol and first results have been published elsewhere.9,25 Briefly, the MMFM study involved a
convenience sample of 100 FPs across five large regions of Switzerland. Eligible participants were
patients with multimorbidity aged >18 years, suffering from 3 CCs on a predefined list of 75 items
identified from the International Classification of Primary Care 2 (ICPC-2).25,26 FPs could subse-
quently add other conditions affecting patients. When available, these additional conditions
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were recoded with their usual ICPC-2 classifications by the research team. Each patient included
gave their written informed consent to participate in the study.
FPs were asked to list the conditions by order of medical importance for each patient on the day
of their inclusion in the study (that is, how patients presented to their FPs on that day). In the present
analysis, positions in this ordering are called the medical priority ranking.
Data are available at the Department of Family Medicine, General Medicine and Public Health
Centre, University of Lausanne.
Statistical analyses
Definitions
In the following analyses, three categories of CCs were defined based on their prevalence in the
sample and their presence or not on the predefined list of 75 items:
1. on the list with a prevalence 5% was termed ’highly prevalent’;
2. on the list with a prevalence <5% was termed ’moderately prevalent’; and
3. not on the list was termed ’other’ and included all the other conditions recorded by the FPs.
This category contained CCs, but also acute conditions, combinations of conditions (such as
asthma and chronic obstructive pulmonary disease listed together), or social problems. The
prevalence of items was not calculated in this heterogeneous category, but the medical prior-
ity rankings which FPs gave to each condition were analysed.
Analyses
The analyses involved three steps.
Step one
The medical priority ranking of each CC on the list was extracted (categories 1 and 2). Each CC’s
prevalence within the sample was calculated, as well as the median and IQR of the medical priority
ranking. The prevalence and median priority ranking of CCs were illustrated using a scatterplot dia-
gram. Prevalence was represented using a logarithmic scale to enhance readability. Spearman’s rho
and Kendal’s tau were calculated to assess the correlation between a CC’s prevalence and the
median level of its medical priority ranking; the null hypothesis of an absence of association was also
tested.
Furthermore, for each patient, the relative priority ranking was calculated by taking the ratio
between the medical priority rank for a given CC and the maximal number of mentioned CCs for
this patient. The following formula was used: 1-(Rank-1)/ (Total number of mentioned CCs-1).
The results were expressed in per cent, where 100% was the highest possible priority and 0% the
lowest.
Step two
The distribution of medical priority rankings for every condition in each of the three categories of
CCs was illustrated using bar charts.
Step three
The research team analysed which conditions FPs retained as the top three medical priorities for
every individual patient. Each patient was classified into one of three groups: the first group’s top
three ranked medical priorities were all ’highly prevalent’ CCs (only category 1). The second group’s
top three ranked medical priorities included 1 ’moderately prevalent’ CC, but there were no
’other’ condition (categories 1 and 2). The third group’s top three ranked medical priorities included
1 ’other’ condition (categories 1, 2, 3).
Furthermore, to illustrate and better understand the distribution of FPs’ medical priority rankings,
some specific subcategories of the ICPC-2 were analysed: cardiovascular and psychiatric conditions,
because of their high prevalence and appearance in numerous clinical recommendations; and malig-
nant neoplasms, because they are not usually integrated into clinical recommendations, but they
usually have a high medical priority.
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All statistics were computed using the R statistical language (version 3.3.2). Figures were made
using the ggplot2 package (version 2.2.1).
Results
General
The MMFM study’s general results have been published elsewhere.9 Briefly, the sample contained
888 patients, with a mean age of 73 years (range 28–98), and 48.2% were male. They were pre-
scribed 8 medications on average (mean 7.7; SD 3.5). The median number of CCs was 5 (range 1–
16; IQR 6–9) for CC categories 1 and 2 combined. By adding category 3 (’others’), the median num-
ber of all conditions rose to 7 (range 3–19; IQR 6–9).
Type and prevalence of the conditions mentioned
Overall, FPs used 74/75 CCs on the predefined list (only ’malignant neoplasm of the nervous system’
was not used), of which 27 had a prevalence 5%. All the FPs added at least one ’other’ condition
at least once, and 90% of them added 6 different ’other’ conditions, with an average of 21 ’other’
conditions mentioned per FP across all their included patients. Only 15% of the patients had exclu-
sively CCs from the predefined list. The 100 FPs recorded a total of 336 different conditions: 74
from the predefined list, and 262 ’others’.
The median medical priority ranking for each CC on the list of 75 is described in Table 1 in rela-
tion to its prevalence (categories 1 and 2). One was the highest medical priority ranking and 19 the
lowest.
For each of the 74/75 CCs (category 1), the medical priority rankings are most of the time highly
variable (Figure 1). Even if a CC had a low median priority ranking, it could be ranked as a high pri-
ority for some patients, including a first, second, or third priority position. It was found that 64/74
CCs (86%) were ranked as the highest medical priority for 1 patient. However, no correlation
was found between the prevalence of a given CC and its median ranking (Spearman’s rho » Ken-
dal’s tau » -0.02; P value » 0.8).
This variability is conserved, even if the relative ranks are used instead of the absolute
ranks (Table 1). Indeed, relative ranks also show that nearly all CCs could be found at nearly every
place of the medical ranking made by the FP, whether the patient had three or 19 CCs.
To illustrate the absence of correlation between prevalence and medical priority ranking, a scat-
terplot diagram was created for the CCs of categories 1 and 2 (Figure 2). Most rare CCs with high
medical priority rankings (upper left quadrant) involved different ICPC-2 categories, without system-
atic distribution: n = 10 neoplasms from different systems, n = 6 psychological, and n = 2 neurologi-
cal CCs. On the other side, high prevalence CCs with high medical priority rankings (upper right
quadrant) most often concerned the ICPC-2 categories cardiovascular (n = 7 CCs), respiratory (n = 2
CCs), metabolic (n = 2 CCs), or psychological (n = 2 CCs).
Types of conditions among the top three medical priorities
Figure 3 illustrates the distribution of CC prevalence per medical priority ranking defined by FPs: a
’highly prevalent’ CC (n = 27/75) was ranked as the first medical priority in 66% of cases, a ’moder-
ately prevalent’ CC was ranked first in 11% of cases. In the remaining 23%, FPs ranked an ’other’
condition as the first medical priority. Response patterns for the second- and third-ranked medical
priorities were similar.
In 33% of patients, FPs ranked three of the 27 ’highly prevalent’ CCs (category 1) as their top
three medical priorities. In 13% of patients, 1 ’moderately prevalent’ CC (category 2) was ranked
among the top three medical priorities, but with no ’other’ condition. In 54% of patients, FPs ranked
an ’other’ condition (category 3) among the top three medical priorities. This distribution is shown in
Figure 4.
To better illustrate the absence of relationship between the prevalence of CCs and their medical
priority ranking the following categories of the ICPC-2 were analysed.
A category K (cardiovascular condition) was recorded 1 time (median 2; IQR 1–3; max 6) in 89%
of the patients (n = 792/888) and in 77% (n = 568/792) of them, FPs ranked 1 K condition among
their top three medical priorities.
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Thirty-nine per cent of patients had 1 category P (psychiatric): condition (n = 347/888), of whom
47% (n = 161/347) had 1 P condition cited among their top three medical priorities.
Of the overall sample, 17% had 1 malignant neoplasm ranked in their list of medical priorities
(n = 156/888), of whom 27% (n = 43/156) had a neoplasm among their top three medical priorities.
Discussion
Summary
The present study analysed FPs’ medical priority rankings for every individual patient
with multimorbidity in primary care. Two important results were found.
First, nearly all the conditions included were to be found at nearly every medical priority ranking
given by the FPs. Indeed, no systematic distribution of medical priority rankings were found for any
given set of CCs; rankings could be different for each patient. In other words, even if a condition
generally had a low medical priority ranking, it could be ranked as a high medical priority for some
patients, including in the first, second, or third positions.
Second, no correlation was found between medical priority ranking and the prevalence of a given
condition: some rare CCs could have a very high medical priority ranking. For example, mental
Figure 1 Boxplot of medical priority rank given by family practitioners to 74 chronic conditions (categories 1 and 2), sorted by mean rank (diamond)
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retardation was described only once, but it was that patient’s top medical priority. The rare CCs
found in the present sample might not necessarily be found in other samples, but the authors never-
theless believe that disparate groups of rarely prevalent CCs with a high medical priority are surely
to be found in all samples of patients with multimorbidity in primary care.
Strengths and limitations
The present study’s main strength is that, to the best of the authors’ knowledge, it was the first
exploratory research on FPs’ rankings of the medical priorities attached to the different conditions
of patients with multimorbidity in a primary care context.
Other strengths were the inclusion of patients with multimorbidity across large regions of Switzer-
land and of younger patients; most studies of multimorbidity investigate patients aged >65 or >80
years. Furthermore, a pre-defined list of 75 CCs was used as a framework, with the possibility of
adding other conditions that FPs felt were relevant. Thus, the authors were able to describe the
great diversity of conditions seen in primary care and provide a fuller picture of FPs’ daily practice.
The study has some limitations. First, a selection bias cannot be excluded as the inclusion criteria
only concerned the 75 CCs on the predefined list. It cannot be certain that every condition not on
this list was recorded. However, if there had been a selection bias, the authors would have expected
the number of conditions seen and the importance of their distribution at the top of the medical pri-
ority rankings to be even higher, thus reinforcing the findings.
Figure 2 Scatterplot of correlation between prevalence and medical priority ranking
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A second potential limitation is that medical priorities may change over time, depending on the
presence of new acute or chronic conditions. The authors’ interpretation of the duration of medical
Figure 3 Relationship between medical priority ranking and category of conditions
Figure 4 Distribution of the three categories of conditions among the top three ranking medical priorities
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priorities was limited because of an absence of information about the severity of the conditions
included, their evolution or the patients’ functional statuses. But as this is the first study describing
FPs’ ranking of medical priorities, it would be interesting if further studies examined how these prior-
ities change over time.
The difficulty inherent in comparing patients with multimorbidity with 3–19 different conditions is
a third limitation. The dispersion of medical priority rankings may be different among patients with
fewer CCs. Nevertheless, sub-analyses by patient subgroup, FPs’ demographic factors, or linguistic
area did not change these analyses (data not shown). And sub-analyses of the relative medical prior-
ity ranking confirmed the authors’ interpretation. Furthermore, it is believed that the highest ranking
of medical priorities recorded by FPs were probably representative of patient’s reality that day, but
that the rankings attributed to the lower-end priorities may have been more arbitrary
(such as deciding whether a CC should be ranked 10 or 11).
Comparison with the literature
An extensive literature search found no published studies to support the present results. However,
some references, especially those evaluating complexity analyses, suggested the importance of
exploring FPs’ opinions on medical priorities among the different CCs that patients present with.27
Thus, to the best of the authors’ knowledge, the present study is the first to analyse FPs’ opinions
on ranking medical priorities when managing patients with multimorbidity.
Implications for practice
Developing better knowledge of what FPs deem to be medical priorities has two important implica-
tions for practice.
First, as some authors have mentioned, knowing FPs’ views on medical priorities would allow bet-
ter comparisons with patients’ priorities, as they may be different.28 Indeed, patients’ priorities may
more often be based on symptomatic problems, whereas FPs may prioritise clinical problems with a
high risk of mortality or morbidity (such as heart diseases or diabetes).18 To illustrate this hypothesis,
supported by the literature, this study showed, for example, that the vast majority of patients
declared pain to be their most important complaint, yet painful conditions only appear in the central
area of the scatterplot diagram, suggesting that pain is not the top medical priority for FPs.29 To
develop better concordance and shared decision-making between patients’ and FPs’ priorities, it
would therefore also be helpful to better understand how FPs prioritise CCs in
patients with multimorbidity. Second, although the highly prevalent CCs found in
patients with multimorbidity have been included in the clinical guidelines, this may still not be suffi-
cient for primary care, where integrating treatments for highly, moderately, and rarely prevalent
acute and chronic conditions is the norm, as this study confirmed.15,20,22 Furthermore, even the new-
est guidelines do not specify the medical priority of the different comorbidities included in them.
The inclusion of neoplasms (17% of cases in the present sample) in this study’s analyses may also
illustrate the importance of exploring medical priority rankings in relation to guidelines. A neoplasm
may be a higher medical priority than hypertension, obesity, or silent risk factors and, indeed, neo-
plasms were ranked among the top three medical priorities in 27% of the patients presenting
with them. However, no information was available about the severity or current state of any specific
CC, therefore a cancer could be a low medical priority if it were in remission. Yet, even though a
neoplasm can be among a patient’s top medical priorities, no guidelines were found in the literature
targeting cancer that indicated how to manage it in patients with multimorbidity in primary care.
In conclusion, this was the first study to explore FPs’ rankings of different conditions by medical
priority when managing patients with multimorbidity in primary care. It found no correlation
between the prevalence of medical conditions and FPs’ rankings of their medical priority. In fact,
there were a great variety of different conditions, and nearly every condition was found among at
least one patient’s top three medical priorities. Furthermore, although highly prevalent CCs appear
frequently in primary care, by definition, the ranking of moderately or rarely prevalent chronic or
acute conditions among the top three medical priorities proved to be the norm, rather than the
exception in the present study. Future studies should investigate how FPs determine the medical pri-
orities of different conditions and whether they match with patients’ priorities. This could lead to
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better adapted guidelines for the management of patients with multimorbidity in primary care and
to a better understanding of the gap between patients’ and FPs’ priorities.
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